Leadership
We are led by a seasoned management team, an experienced board of directors and accomplished scientific founders with extensive experience across the biotechnology and pharmaceutical industries.
Dr. Samarth Kulkarni
Chief Executive Officer
Read bio
Dr. Samarth Kulkarni
Chief Executive Officer
Dr. Steve Caffé
Head of Regulatory Affairs
Read bio
Dr. Steve Caffé
Head of Regulatory Affairs
Philippe Drouet
Chief Commercial Officer
Read bio
Philippe Drouet
Chief Commercial Officer
Dr. Tony Ho
Head of Research and Development
Read bio
Dr. Tony Ho
Head of Research and Development
James Kasinger
General Counsel and Secretary to the Board of Directors
Read bio
James Kasinger
General Counsel and Secretary to the Board of Directors
Stephen Kennedy
Head of Technical Operations
Read bio
Stephen Kennedy
Head of Technical Operations
Dr. Lawrence Klein
Chief Operating Officer
Read bio
Dr. Lawrence Klein
Chief Operating Officer
Dr. John Leonard
Head of In Vivo and Hematology Research and Translation
Read bio
Dr. John Leonard
Head of In Vivo and Hematology Research and Translation
John Martin
Head of Government Affairs
Read bio
John Martin
Head of Government Affairs
Megan Wherry Menner
Head of Human Resources
Read bio
Megan Wherry Menner
Head of Human Resources
Dr. Rodger Novak
Co-Founder and President
Read bio
Dr. Rodger Novak
Co-Founder and President
Dr. Jon Terrett
Head of Immuno-Oncology Research and Translation
Read bio
Dr. Jon Terrett
Head of Immuno-Oncology Research and Translation
Michael Tomsicek
Chief Financial Officer
Read bio
Michael Tomsicek
Chief Financial Officer
Shelby Walker
Head of Intellectual Property
Read bio
Shelby Walker
Head of Intellectual Property
You are now leaving the CRISPR Therapeutics website.
CRISPR Therapeutics is not responsible for the content or availability of third-party sites.
Continue